心臓AIモニタリングと診断の世界市場レポート 2025年

心臓AIモニタリングと診断市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR26.6％で55億4,000万米ドルに成長します。予測期間の成長は、ウェアラブルデバイスとIoTデバイスの拡大、遠隔医療と遠隔モニタリングの採用拡大、ビッグデータ分析と予測モデリングの統合、患者中心のケアと遠隔患者エンゲージメントの重視、ヘルスケアインフラ開発に起因します。予測期間の主な動向には、ウェアラブル機器とAIの統合、個別化リスク評価と治療計画、心血管イベントの予測分析、マルチモーダルデータソースの統合、相互運用性とデータ統合標準などがあります。

心血管疾患（CVDs）の有病率の上昇は、心臓AIモニタリングと診断市場の成長を促進すると予想されます。CVDは、脳血管疾患、冠状動脈性心疾患、リウマチ性心疾患など、心臓や血管に影響を与えるさまざまな疾患を含みます。心臓AIモニタリングと診断は、心血管疾患の早期診断、リスク評価、個別化治療を促進し、患者の転帰を改善します。例えば、2024年9月、英国を拠点とする心臓血管研究慈善団体であるBritish Heart Foundationのデータによると、英国では約760万人が心臓・循環器系疾患に罹患しており、そのうち男性は約400万人、女性は約360万人が罹患しています。これらの疾患は英国における全死亡の約27％を占め、年間17万人以上、1日当たり約480人、3分に1人が死亡していることになります。その結果、心血管疾患の発生率の増加が心臓AIモニタリングと診断市場の成長に拍車をかけています。

心臓AIモニタリングと診断市場で事業を展開する主要企業は、人工知能ベースの植え込み型心臓モニターなどの技術主導型医療機器の開発に力を注ぎ、市場での地位を確固たるものにしています。人工知能ベースの植え込み型心臓モニターは、心臓血管ヘルスケアにおける画期的なイノベーションであり、心機能の継続的かつ正確なモニタリングを提供します。例えば、2023年5月、ドイツに本社を置く著名な心血管バイオメディカル研究・技術企業であるBiotronikは、BIOMONITOR IV植込み型心臓モニター（ICM）のFDA承認を発表しました。人工知能を活用したBIOTRONIKの最先端のSmartECGアルゴリズムを搭載したBIOMONITOR IV ICMは、心臓モニタリングの精度に新たな基準を打ち立てます。高度なアルゴリズムを活用することで、SmartECGテクノロジーは、本物の心臓エピソードの高い検出率を維持しながら、誤認識を大幅に低減します。この検出精度の向上により、ヘルスケア専門家は迅速かつ正確な診断を行うことができ、患者ケアと転帰を最適化することができます。さらに、BIOMONITOR IV ICMは、早発性心室収縮（PVC）や早発性心房収縮（PAC）といった異なるタイプの心収縮を区別し、診断能力と臨床的有用性をさらに高めます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界心臓AIモニタリングと診断 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の心臓AIモニタリングと診断市場：成長率分析
• 世界の心臓AIモニタリングと診断市場の実績：規模と成長, 2019-2024
• 世界の心臓AIモニタリングと診断市場の予測：規模と成長, 2024-2029, 2034F
• 世界心臓AIモニタリングと診断総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の心臓AIモニタリングと診断市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓診断
• 心臓モニタリング
• 世界の心臓AIモニタリングと診断市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ソフトウェア
• ハードウェア
• 世界の心臓AIモニタリングと診断市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 虚血性心疾患または冠動脈疾患（CAD）
• 不整脈
• 虚血性脳卒中
• その他の用途
• 世界の心臓AIモニタリングと診断市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断センター
• その他のエンドユーザー
• 世界の心臓AIモニタリングと診断市場心臓診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心電図分析
• 心エコー検査分析
• 心臓画像診断
• バイオマーカー分析
• 世界の心臓AIモニタリングと診断市場、心臓モニタリングのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ウェアラブル心臓モニター
• 遠隔患者モニタリングシステム
• 埋め込み型心臓デバイス
• 継続的な心電図モニタリングシステム

第7章 地域別・国別分析

• 世界の心臓AIモニタリングと診断市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の心臓AIモニタリングと診断市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 心臓AIモニタリングと診断市場：競合情勢
• 心臓AIモニタリングと診断市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Boston Scientific Corporation
• ZOLL Medical Corporation
• Canon Medical Systems Corporation
• Biotronik SE & Co. KG
• iRhythm Technologies Inc.
• Tempus Labs Inc.
• Viz.ai Inc.
• HeartFlow Inc.
• Aidoc
• Eko Devices Inc.
• CardioFocus Inc.
• Circle Cardiovascular Imaging Inc.
• Ultromics Limited.
• Cathworks
• Medicalgorithmics S.A.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 心臓AIモニタリングと診断市場2029：新たな機会を提供する国
• 心臓AIモニタリングと診断市場2029：新たな機会を提供するセグメント
• 心臓AIモニタリングと診断市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cardiac AI monitoring and diagnostics involve the application of artificial intelligence (AI) technologies in the field of cardiology to monitor and diagnose various cardiovascular conditions. This utilizes advanced algorithms and machine learning techniques to analyze data from cardiac monitoring devices, such as electrocardiograms (ECGs).

The main categories of cardiac AI monitoring and diagnostics are cardiac diagnostics and cardiac monitoring. Cardiac diagnostics encompass methods and procedures used to identify heart conditions associated with unhealthy or pathologic heart function. The products in this category include software and hardware used in applications such as ischemic heart diseases or coronary artery disease (CAD), cardiac arrhythmias, ischemic stroke, and others. End users of these cardiac AI solutions include hospitals, diagnostic centers, and various healthcare facilities.

The cardiac AI monitoring and diagnostics research report is one of a series of new reports from The Business Research Company that provides cardiac AI monitoring and diagnostics market statistics, including the cardiac AI monitoring and diagnostics industry's global market size, regional shares, competitors with an cardiac AI monitoring and diagnostics market share, detailed cardiac AI monitoring and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac AI monitoring and diagnostics industry. This cardiac AI monitoring and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiac ai monitoring and diagnostics market size has grown exponentially in recent years. It will grow from $1.71 billion in 2024 to $2.16 billion in 2025 at a compound annual growth rate (CAGR) of 26.4%. The growth in the historic period can be attributed to aging population demographics, rise in remote patient monitoring, increased healthcare expenditure, clinical research and validation studies, focus on preventive healthcare.

The cardiac ai monitoring and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $5.54 billion in 2029 at a compound annual growth rate (CAGR) of 26.6%. The growth in the forecast period can be attributed to expansion of wearable and IoT devices, increasing adoption of telemedicine and remote monitoring, integration of big data analytics and predictive modeling, focus on patient-centered care and remote patient engagement, healthcare infrastructure development. Major trends in the forecast period include integration of AI with wearable devices, personalized risk assessment and treatment planning, predictive analytics for cardiovascular events, integration of multimodal data sources, interoperability and data integration standards.

The rising prevalence of cardiovascular diseases (CVDs) is expected to drive growth in the cardiac AI monitoring and diagnostics market. CVDs encompass a range of conditions affecting the heart and blood vessels, including cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Cardiac AI monitoring and diagnostics facilitate early diagnosis, risk assessment, and personalized treatment for cardiovascular conditions, improving patient outcomes. For example, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with around 4 million men and 3.6 million women affected. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or about 480 deaths per day, equivalent to one death every three minutes. Consequently, the increasing incidence of cardiovascular diseases is fueling growth in the cardiac AI monitoring and diagnostics market.

Leading companies operating in the cardiac AI monitoring and diagnostics market are directing their efforts towards the development of technology-driven medical devices, such as artificial intelligence-based implantable cardiac monitors, to solidify their position in the market. Artificial intelligence-based implantable cardiac monitors represent a groundbreaking innovation in cardiovascular healthcare, offering continuous and accurate monitoring of cardiac function. For example, in May 2023, Biotronik, a renowned cardiovascular biomedical research and technology company based in Germany, announced the FDA approval of its BIOMONITOR IV implantable cardiac monitor (ICM). Equipped with BIOTRONIK's cutting-edge SmartECG algorithm powered by artificial intelligence, the BIOMONITOR IV ICM sets a new standard in cardiac monitoring accuracy. By leveraging advanced algorithms, the SmartECG technology significantly reduces false identifications while maintaining a high detection rate for genuine cardiac episodes. This enhancement in detection accuracy empowers healthcare professionals to make prompt and precise diagnoses, thus optimizing patient care and outcomes. Furthermore, the BIOMONITOR IV ICM distinguishes between different types of cardiac contractions, such as premature ventricular contractions (PVCs) and premature atrial contractions (PACs), further enhancing its diagnostic capabilities and clinical utility.

In January 2022, Koninklijke Philips N.V., a healthcare technology company headquartered in the Netherlands, completed the acquisition of Cardiologs Technologies SAS, a medical technology company based in France, for an undisclosed sum. This strategic move positions Cardiologs to enhance Philips' cardiac monitoring and diagnostics portfolio through the integration of innovative software solutions, electrocardiogram (ECG) analysis, and reporting services. Cardiologs Technologies SAS specializes in optimizing cardiac diagnostics through the utilization of artificial intelligence (AI) and cloud technologies, aligning with Philips' commitment to advancing healthcare through cutting-edge innovations.

Major companies operating in the cardiac ai monitoring and diagnostics market report are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.

North America was the largest region in the cardiac AI monitoring and diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac ai monitoring and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac AI monitoring and diagnostics market consists of revenues earned by entities by providing services such as ST-segment monitoring, arrhythmia detection, heart rate variability analysis, risk stratification, and echocardiogram interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac AI monitoring and diagnostics market also includes sales of echocardiography devices, cardiac MRI and CT analysis, electrocardiogram (ECG) analysis tools, and wearable devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac AI Monitoring And Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac ai monitoring and diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac ai monitoring and diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac ai monitoring and diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Cardiac Diagnostics; Cardiac Monitoring
• 2) By Product: Software; Hardware
• 3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD); Cardiac Arrhythmias; Ischemic Stroke; Other Applications
• 4) By End Users: Hospitals; Diagnostic Centers; Other End Users
• Subsegments:
• 1) By Cardiac Diagnostics: ECG Analysis; Echocardiography Analysis; Cardiac Imaging; Biomarker Analysis
• 2) By Cardiac Monitoring: Wearable Cardiac Monitors; Remote Patient Monitoring Systems; Implantable Cardiac Devices; Continuous ECG Monitoring Systems
• Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac AI Monitoring And Diagnostics Market Characteristics

3. Cardiac AI Monitoring And Diagnostics Market Trends And Strategies

4. Cardiac AI Monitoring And Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiac AI Monitoring And Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cardiac AI Monitoring And Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cardiac AI Monitoring And Diagnostics Market Growth Rate Analysis
• 5.4. Global Cardiac AI Monitoring And Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cardiac AI Monitoring And Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cardiac AI Monitoring And Diagnostics Total Addressable Market (TAM)

6. Cardiac AI Monitoring And Diagnostics Market Segmentation

• 6.1. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Diagnostics
• Cardiac Monitoring
• 6.2. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Hardware
• 6.3. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ischemic Heart Diseases Or Coronary Artery Disease (CAD)
• Cardiac Arrhythmias
• Ischemic Stroke
• Other Applications
• 6.4. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Centers
• Other End Users
• 6.5. Global Cardiac AI Monitoring And Diagnostics Market, Sub-Segmentation Of Cardiac Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ECG Analysis
• Echocardiography Analysis
• Cardiac Imaging
• Biomarker Analysis
• 6.6. Global Cardiac AI Monitoring And Diagnostics Market, Sub-Segmentation Of Cardiac Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wearable Cardiac Monitors
• Remote Patient Monitoring Systems
• Implantable Cardiac Devices
• Continuous ECG Monitoring Systems

7. Cardiac AI Monitoring And Diagnostics Market Regional And Country Analysis

• 7.1. Global Cardiac AI Monitoring And Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cardiac AI Monitoring And Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market

• 8.1. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac AI Monitoring And Diagnostics Market

• 9.1. China Cardiac AI Monitoring And Diagnostics Market Overview
• 9.2. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac AI Monitoring And Diagnostics Market

• 10.1. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac AI Monitoring And Diagnostics Market

• 11.1. Japan Cardiac AI Monitoring And Diagnostics Market Overview
• 11.2. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac AI Monitoring And Diagnostics Market

• 12.1. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac AI Monitoring And Diagnostics Market

• 13.1. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac AI Monitoring And Diagnostics Market

• 14.1. South Korea Cardiac AI Monitoring And Diagnostics Market Overview
• 14.2. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac AI Monitoring And Diagnostics Market

• 15.1. Western Europe Cardiac AI Monitoring And Diagnostics Market Overview
• 15.2. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac AI Monitoring And Diagnostics Market

• 16.1. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac AI Monitoring And Diagnostics Market

• 17.1. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac AI Monitoring And Diagnostics Market

• 18.1. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac AI Monitoring And Diagnostics Market

• 19.1. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac AI Monitoring And Diagnostics Market

• 20.1. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac AI Monitoring And Diagnostics Market

• 21.1. Eastern Europe Cardiac AI Monitoring And Diagnostics Market Overview
• 21.2. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac AI Monitoring And Diagnostics Market

• 22.1. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac AI Monitoring And Diagnostics Market

• 23.1. North America Cardiac AI Monitoring And Diagnostics Market Overview
• 23.2. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac AI Monitoring And Diagnostics Market

• 24.1. USA Cardiac AI Monitoring And Diagnostics Market Overview
• 24.2. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac AI Monitoring And Diagnostics Market

• 25.1. Canada Cardiac AI Monitoring And Diagnostics Market Overview
• 25.2. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac AI Monitoring And Diagnostics Market

• 26.1. South America Cardiac AI Monitoring And Diagnostics Market Overview
• 26.2. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac AI Monitoring And Diagnostics Market

• 27.1. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac AI Monitoring And Diagnostics Market

• 28.1. Middle East Cardiac AI Monitoring And Diagnostics Market Overview
• 28.2. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac AI Monitoring And Diagnostics Market

• 29.1. Africa Cardiac AI Monitoring And Diagnostics Market Overview
• 29.2. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac AI Monitoring And Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Cardiac AI Monitoring And Diagnostics Market Competitive Landscape
• 30.2. Cardiac AI Monitoring And Diagnostics Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac AI Monitoring And Diagnostics Market Other Major And Innovative Companies

• 31.1. Boston Scientific Corporation
• 31.2. ZOLL Medical Corporation
• 31.3. Canon Medical Systems Corporation
• 31.4. Biotronik SE & Co. KG
• 31.5. iRhythm Technologies Inc.
• 31.6. Tempus Labs Inc.
• 31.7. Viz.ai Inc.
• 31.8. HeartFlow Inc.
• 31.9. Aidoc
• 31.10. Eko Devices Inc.
• 31.11. CardioFocus Inc.
• 31.12. Circle Cardiovascular Imaging Inc.
• 31.13. Ultromics Limited.
• 31.14. Cathworks
• 31.15. Medicalgorithmics S.A.

32. Global Cardiac AI Monitoring And Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac AI Monitoring And Diagnostics Market

34. Recent Developments In The Cardiac AI Monitoring And Diagnostics Market

35. Cardiac AI Monitoring And Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Cardiac AI Monitoring And Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cardiac AI Monitoring And Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cardiac AI Monitoring And Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer